NDC 44911-0240-1 Multi-phenolic

Serotonin Hydrochloride, 5-hydroxytryptophan, Acetaldehyde, Acetylcholine Chloride, Apiolum, Ascorbic Acid, Aspartame, Butylated Hydroxytoluene, Caffeic Acid, Chlorogenic Acid, Cinnamic Acid, Coniferyl Alcohol, Coumarinum, Dopamine Hydrochloride, Estradiol, Gallicum Acidum, Gamma Aminobutyric Acid, Histaminum Hydrochloricum, Hydrocortisone (cortisol), Indolum, L-dopa, Malvin, Mannan, Melatonin, Menadione, Norepinephrine, Octopamine, Phenyl Isothiocyanate, Phloridzinum, Piperine, Progesterone, Pyrrole

NDC Package Code 44911-0240-1

The NDC Code 44911-0240-1 is assigned to a package of 30 ml in 1 bottle, dropper of Multi-phenolic, a human over the counter drug labeled by Energique, Inc.. The product's dosage form is liquid and is administered via oral form.

Field Name Field Value
NDC Code 44911-0240-1
Package Description 30 mL in 1 BOTTLE, DROPPER
Proprietary Name Multi-phenolic What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Serotonin Hydrochloride, 5-hydroxytryptophan, Acetaldehyde, Acetylcholine Chloride, Apiolum, Ascorbic Acid, Aspartame, Butylated Hydroxytoluene, Caffeic Acid, Chlorogenic Acid, Cinnamic Acid, Coniferyl Alcohol, Coumarinum, Dopamine Hydrochloride, Estradiol, Gallicum Acidum, Gamma Aminobutyric Acid, Histaminum Hydrochloricum, Hydrocortisone (cortisol), Indolum, L-dopa, Malvin, Mannan, Melatonin, Menadione, Norepinephrine, Octopamine, Phenyl Isothiocyanate, Phloridzinum, Piperine, Progesterone, Pyrrole What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
11-Digit NDC Billing Format 44911024001 NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
Product Type Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Labeler Name Energique, Inc.
Dosage Form Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s)
  • Oral - Administration to or by way of the mouth.
Active Ingredient(s)
  • SEROTONIN HYDROCHLORIDE 4 [hp_X]/mL
  • OXITRIPTAN 6 [hp_X]/mL
  • ACETALDEHYDE 6 [hp_X]/mL
  • ACETYLCHOLINE CHLORIDE 6 [hp_X]/mL
  • APIOLE (PARSLEY) 6 [hp_X]/mL
  • ASCORBIC ACID 6 [hp_X]/mL
  • ASPARTAME 6 [hp_X]/mL
  • BUTYLATED HYDROXYTOLUENE 6 [hp_X]/mL
  • CAFFEIC ACID 6 [hp_X]/mL
  • CHLOROGENIC ACID 6 [hp_X]/mL
  • CINNAMIC ACID 6 [hp_X]/mL
  • CONIFERYL ALCOHOL 6 [hp_X]/mL
  • COUMARIN 6 [hp_X]/mL
  • DOPAMINE HYDROCHLORIDE 6 [hp_X]/mL
  • ESTRADIOL 6 [hp_X]/mL
  • GALLIC ACID MONOHYDRATE 6 [hp_X]/mL
  • .GAMMA.-AMINOBUTYRIC ACID 6 [hp_X]/mL
  • HISTAMINE DIHYDROCHLORIDE 6 [hp_X]/mL
  • HYDROCORTISONE 6 [hp_X]/mL
  • INDOLE 6 [hp_X]/mL
  • LEVODOPA 6 [hp_X]/mL
  • MALVIN 6 [hp_X]/mL
  • YEAST MANNAN 6 [hp_X]/mL
  • MELATONIN 6 [hp_X]/mL
  • MENADIONE 6 [hp_X]/mL
  • NOREPINEPHRINE 6 [hp_X]/mL
  • OCTOPAMINE HYDROCHLORIDE 6 [hp_X]/mL
  • PHENYL ISOTHIOCYANATE 6 [hp_X]/mL
  • PHENYLALANINE 6 [hp_X]/mL
  • PHLORIZIN 6 [hp_X]/mL
  • PIPERINE 6 [hp_X]/mL
  • PROGESTERONE 6 [hp_X]/mL
  • PYRROLE 6 [hp_X]/mL
  • QUERCETIN 6 [hp_X]/mL
  • RUTIN 6 [hp_X]/mL
  • SALSOLINOL HYDROCHLORIDE 6 [hp_X]/mL
  • TAURINE 6 [hp_X]/mL
  • CANDIDA ALBICANS 12 [hp_X]/mL
Sample Package No Sample Package?
This field Indicates whether this package is a sample packaging or not.
Marketing Category UNAPPROVED HOMEOPATHIC - What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date 08-11-2015 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
End Marketing Date 02-17-2023 What is the End Marketing Date?
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Exclude Flag N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

NDC Code Structure

  • 44911 - Energique, Inc.
    • 44911-0240 - Multi-phenolic
      • 44911-0240-1 - 30 mL in 1 BOTTLE, DROPPER

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.